Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DiCE Molecules
Biotech
DiCE Molecules: another preclinical bio rolling dice on an IPO
DiCE, a preclinical, oral therapeutics biotech, will roll its dice to Wall Street to bankroll its chances against Cosentyx, Taltx and others.
Kyle LaHucik
Aug 26, 2021 9:40am
DiCE bags $80M to roll oral IL-17 psoriasis med into the clinic
Jan 8, 2021 10:52am
Koller's insitro snaps up Haystack Sciences
Oct 23, 2020 8:13am
Genentech, DiCE ally to go after hard-to-drug targets
Dec 19, 2017 7:00am
Astellas pens pact to discover drugs in X-Chem’s library
Mar 21, 2017 3:15am